fp0005354_10q.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q
 
(Mark One)
   
(X)
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d)
 
 
OF THE SECURITIES EXCHANGE ACT OF 1934
 
     
 
For the quarterly period ended June 30, 2012
 
     
(   )
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
 
 
OF THE SECURITIES EXCHANGE ACT OF 1934
 

For the transition period from ________to____________

Commission file number 0-22904

PARKERVISION, INC.
(Exact name of registrant as specified in its charter)

Florida
 
59-2971472
(State or other jurisdiction of
 
I.R.S. Employer Identification No.
incorporation or organization)
   

7915 Baymeadows Way, Suite 400
 Jacksonville, Florida 32256
(Address of principal executive offices)

(904) 732-6100
(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  X     No __.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such file).    
Yes  X     No __.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.   See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large accelerated filer
__
Accelerated filer
__
Non-accelerated filer
__ (Do not check if asmaller reporting company)
Smaller reporting company
 X 
       

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  
Yes __    No  X .

As of August 6, 2012, 78,305,174 shares of the issuer’s common stock, $.01 par value, were outstanding.
 
 
 

 

 
TABLE OF CONTENTS

   
PART I -  FINANCIAL INFORMATION
 
   
Item 1.    Financial Statements (Unaudited)
3
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
11
Item 3.    Quantitative and Qualitative Disclosures About Market Risk
15
Item 4.    Controls and Procedures
15
   
PART II - OTHER INFORMATION
 
Item 1.    Legal Proceedings
16
Item 1A. Risk Factors
16
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
16
Item 3.    Defaults Upon Senior Securities
16
Item 4.    Mine Safety Disclosures
16
Item 5.    Other Information
16
Item 6.    Exhibits
16
   
SIGNATURES
18
   
EXHIBIT INDEX
19

 
2

 
 
PART I - FINANCIAL INFORMATION

ITEM 1.  Financial Statements (Unaudited)

PARKERVISION, INC.

BALANCE SHEETS

(UNAUDITED)

   
June 30,
2012
   
December 31,
2011
 
CURRENT ASSETS:
           
   Cash and cash equivalents
  $ 238,722     $ 213,438  
   Available for sale securities
    6,642,573       5,026,398  
   Prepaid expenses and other
    650,670       661,788  
          Total current assets
    7,531,965       5,901,624  
                 
PROPERTY AND EQUIPMENT, net
    422,833       351,285  
                 
INTANGIBLE ASSETS, net
    9,027,147       9,004,263  
                 
OTHER ASSETS, net
    473,187       584,799  
          Total assets
  $ 17,455,132     $ 15,841,971  
                 
CURRENT LIABILITIES:
               
   Accounts payable
  $ 222,849     $ 613,806  
   Accrued expenses:
        Salaries and wages
    317,451       252,928  
        Professional fees
    677,031       404,069  
        Other accrued expenses
    117,559       16,867  
   Deferred rent, current portion
    84,164       75,804  
          Total current liabilities
    1,419,054       1,363,474  
                 
LONG TERM LIABILITIES
               
Capital lease, net of current portion
    45,807       0  
Deferred rent, net of current portion
    93,254       137,878  
          Total long term liabilities
    139,061       137,878  
          Total liabilities
    1,558,115       1,501,352  
                 
COMMITMENTS AND CONTINGENCIES (Notes 8 and 11)
               
                 
SHAREHOLDERS' EQUITY:
               
   Common stock, $.01 par value, 100,000,000 shares authorized, 77,846,959 and 67,573,775 shares issued and
outstanding at June 30, 2012 and December 31,
2011, respectively
        778,469           675,738  
Accumulated other comprehensive loss
    0       (10,418 )
   Warrants outstanding
    1,323,305       8,649,786  
   Additional paid-in capital
    264,740,426       246,842,116  
   Accumulated deficit
    (250,945,183 )     (241,816,603 )
          Total shareholders' equity
    15,897,017       14,340,619  
          Total liabilities and shareholders' equity
  $ 17,455,132     $ 15,841,971  
 
The accompanying notes are an integral part of these unaudited financial statements.

 
3

 

PARKERVISION, INC.

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

   
Three Months Ended June 30,
   
Six Months Ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
                         
                         
Engineering services revenue
  $ 0     $ 0     $ 0     $ 0  
Cost of sales
    0       0       0       0  
Gross margin
    0       0       0       0  
                                 
                                 
Research and development expenses
    1,789,313       2,185,942       3,827,836       4,123,663  
Marketing and selling expenses
    362,715       337,748       758,073       679,570  
General and administrative expenses
    2,929,019       1,046,507       4,569,735       2,154,488  
Total operating expenses
    5,081,047       3,570,197       9,155,644       6,957,721  
                                 
Interest and other income
    23,409       33,776       30,262       52,864  
Interest expense
    (2,889 )     (970 )     (3,198 )     (2,267 )
Total interest and other income and interest expense
    20,520       32,806       27,064       50,597  
                                 
Net loss
    (5,060,527 )     (3,537,391 )     (9,128,580 )     (6,907,124 )
                                 
Other comprehensive (loss) income, net of tax:
                               
Unrealized (loss) gain on available for sale securities
    (32 )     14,257       10,418       14,914  
Other comprehensive (loss) income, net of tax
    (32 )     14,257       10,418       14,914  
Comprehensive loss
  $ (5,060,559 )   $ (3,523,134 )   $ (9,118,162 )   $ (6,892,210 )
                                 
Basic and diluted net loss per common share
  $ (0.07 )   $ (0.06 )   $ (0.13 )   $ (0.12 )

The accompanying notes are an integral part of these unaudited financial statements.

 
4

 

PARKERVISION, INC.

STATEMENTS OF CASH FLOWS

(UNAUDITED)

   
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
   
2012
   
2011
   
2012
   
2011
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                       
Net loss
  $ (5,060,527 )   $ (3,537,391 )   $ (9,128,580 )   $ (6,907,124 )
Adjustments to reconcile net loss to net cash used in operating activities:
                               
Depreciation and amortization
    308,322       336,095       615,688       669,569  
Share-based compensation
    1,120,482       558,293       1,443,598       1,013,415  
Loss on disposal of assets
    895       0       895       0  
Realized (gain) loss on available for sale securities
    (32 )     1,017       2,151       5,131  
Changes in operating assets and liabilities:
                               
Prepaid expenses and other assets
    (32,813 )     69,516       122,730       203,074  
Accounts payable and accrued expenses
    (176,287 )     (154,658 )     37,592       148,168  
Deferred rent
    (18,762 )     (16,137 )     (36,264 )     (9,208 )
Total adjustments
    1,201,805       794,126       2,186,390       2,030,149  
Net cash used in operating activities
    (3,858,722 )     (2,743,265 )     (6,942,190 )     (4,876,975 )
                                 
CASH FLOWS FROM INVESTING ACTIVITIES:
                               
Purchase of investments available for sale
    (7,763,873 )     (3,375,343 )     (7,772,908 )     (3,396,993 )
Proceeds from sale of investments
    2,690,000       2,300,000       6,165,000       4,575,000  
Payments for patent costs and other intangible assets
    (285,169 )     (154,012 )     (537,901 )     (352,668 )
Purchases of property and equipment
    (6,545 )     (32,282 )     (101,189 )     (52,310 )
Net cash (used in) provided by investing activities
    (5,365,587 )     (1,261,637 )     (2,246,998 )     773,029  
                                 
CASH FLOWS FROM FINANCING ACTIVITIES:
                               
Net proceeds from issuance of common stock in public and private offerings
    8,318,371       (62,499 )     8,318,371       4,086,826  
Net proceeds from exercise of options and warrants
    912,591       (36,991 )     912,591       68,259  
Principal payments on capital lease obligation
    (9,478 )     (6,351 )     (16,490 )     (12,496 )
Net cash provided by (used in) financing activities
    9,221,484       (105,841 )     9,214,472       4,142,589  
                                 
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
    (2,825 )     (4,110,743 )     25,284       38,643  
                                 
CASH AND CASH EQUIVALENTS, beginning of period
    241,547       4,362,784       213,438       213,398  
CASH AND CASH EQUIVALENTS, end of period
  $ 238,722     $ 252,041     $ 238,722     $ 252,041  
                                 
SUPPLEMENTAL SCHEDULE OF NON-CASH ACTIVITIES:
                               
Purchase of equipment under capital lease
  $ 71,925     $ 0     $ 71,925     $ 0  
Key-man life insurance premiums (Note 7)
  $ 0     $ 0     $ 29,330     $ 45,780  

The accompanying notes are an integral part of these unaudited financial statements.
 
 
5

 
 
PARKERVISION, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS

(UNAUDITED)
 
1.  Description of Business

ParkerVision, Inc. (“We”, the “Company”, or “ParkerVision”) is in the business of innovating fundamental wireless technologies.   We design, develop and market our proprietary radio frequency (“RF”) technologies and products for use in semiconductor circuits for wireless communication products.   Our business is expected to include licensing of our intellectual property and/or the sale of integrated circuits based on our technology for incorporation into wireless devices designed by our customers.   In addition, from time to time, we offer engineering consulting and design services to our customers, for a negotiated fee, to assist them in developing prototypes and/or products incorporating our technologies.

2.  Liquidity and Going Concern

Our financial statements were prepared assuming we would continue as a going concern, which contemplates that we will continue in operation for the foreseeable future and will be able to realize assets and settle liabilities and commitments in the normal course of business.  These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that could result should we be unable to continue as a going concern.

Our future business plans call for continued investment in sales, marketing, customer support and product development for our technologies and products, as well as investment in continued protection of our intellectual property including prosecution of new patents and defense of existing patents.  Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies, our ability to secure a reasonable share of the market through additional product offerings with our current customers and/or the addition of new customers, and our ability to defend our intellectual property.

Our revenue for 2012, if any, will not be sufficient to cover our operational expenses for 2012, and we expect that our expected continued losses and use of cash will be funded from our cash, cash equivalents and available for sale securities of $6.9 million at June 30, 2012.  We believe these resources may be sufficient to support our liquidity requirements through 2012; however, these resources will not be sufficient to support our liquidity requirements for the next twelve months without further cost containment measures that, if implemented, may jeopardize our future growth plans.  These circumstances raise substantial doubt about our ability to continue as a going concern.   

We believe we may be able to meet future liquidity needs through the issuance of equity securities under our outstanding shelf registration statement or in private placements or through short or long-term debt financing, although there can be no assurance that such financing will be available to us.  We currently have no significant long-term debt obligations.

We operate in a highly competitive industry with rapidly changing and evolving technologies.  Many of our potential competitors have substantially greater financial, technical and other resources.  We have made significant investments in developing our technologies and products, the returns on which are dependent upon the generation of future revenues for realization.  The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and products to offset expenses.  In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or further reduce operating costs.  Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or further reduce operating costs could have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.
 
 
6

 

3.  Basis of Presentation

The accompanying unaudited financial statements for the period ended June 30, 2012 were prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Operating results for the three and six months ended June 30, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012 or future years.  All normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations have been included.

The year-end balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.  These interim financial statements should be read in conjunction with our latest Annual Report on Form 10-K for the year ended December 31, 2011.

4.   Accounting Policies

In May 2011, the FASB issued Accounting Standards Update 2011-04 “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” (“ASU 2011-04”).   ASU 2011-04 provides a consistent definition of fair value to ensure fair value measurement and disclosure requirements are similar between U.S. Generally Accepted Accounting Principles and International Financial Reporting Standards.  ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements.  This guidance is effective for interim and annual periods during 2012 and will be applied prospectively.  The adoption of this guidance had no impact on our financial statements.

There have been no other changes in accounting policies from those stated in the Annual Report on Form 10-K for the year ended December 31, 2011.

5.   Loss per Common Share

Basic loss per common share is determined based on the weighted-average number of common shares outstanding during each period.  Diluted loss per common share is the same as basic loss per common share as all common share equivalents are excluded from the calculation, as their effect is anti-dilutive. The weighted average number of common shares outstanding for the three months ended June 30, 2012 and 2011 were 74,581,697 and 59,054,228, respectively.  The weighted average number of common shares outstanding for the six months ended June 30, 2012 and 2011were 71,094,403 and 55,992,506, respectively.

Options and warrants to purchase 8,984,639 and 9,672,567 shares of common stock were outstanding at June 30, 2012 and 2011, respectively.  In addition, unvested RSUs, representing 602,168 and 22,915 shares of common stock, were outstanding at June 30, 2012 and 2011, respectively.   These options, warrants and RSUs were excluded from the computation of diluted loss per common share as their effect would have been anti-dilutive.

 
7

 

6.   Intangible Assets

Intangible assets consist of the following:
 
   
June 30, 2012
 
   
Gross Carrying
Amount
   
Accumulated
Amortization
   
Net Book
 Value
 
Patents and copyrights
  $ 17,822,157     $ 8,795,010     $ 9,027,147  
Prepaid licensing fees
    554,000       554,000       0  
    $ 18,376,157     $ 9,349,010     $ 9,027,147  
                         
 
   
December 31, 2011
 
   
Gross Carrying
Amount
   
Accumulated
Amortization
   
Net Book
 Value
 
Patents and copyrights
  $ 17,284,255     $ 8,279,992     $ 9,004,263  
Prepaid licensing fees
    554,000       554,000       0  
    $ 17,838,255     $ 8,833,992     $ 9,004,263  
                         
 
7.  Other Assets

Other assets include the cash surrender value of key-man life insurance policies that we maintain for certain named executive officers. In January 2012, one of these policies was surrendered for approximately $120,000 which represents the face value of the policy less all policy loans and unpaid interest.  For the six months ended June 30, 2012, we paid premiums on the one remaining policy totaling approximately $29,000 using annual policy dividends and a loan against the policy in the amount of approximately $22,000.  For the six months ended June 30, 2011, we paid aggregate premiums on these policies totaling approximately $46,000 using annual policy dividends and a loan against one of the policies in the amount of approximately $16,000.   The aggregate cash surrender value of these policies, net of policy loans and accrued interest, was approximately $452,000 and $562,000 at June 30, 2012 and December 31, 2011, respectively.

8.  Share-Based Compensation

There has been no material change in the assumptions used to compute the fair value of our equity awards, nor in the method used to account for share-based compensation from those stated in our Annual Report on Form 10-K for the year ended December 31, 2011.

The following table presents share-based compensation expense included in our statements of operations for the three and six months ended June 30, 2012 and 2011, respectively:
 
   
Three months ended June 30,
   
Six months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Research and development expense
  $ 77,677     $ 345,834     $ 161,660     $ 550,278  
Sales and marketing expense
    19,277       41,682       37,886       94,075  
General and administrative expense
    1,023,528       170,777       1,244,052       369,062  
   Total share-based expense
  $ 1,120,482     $ 558,293     $ 1,443,598     $ 1,013,415  
                                 
 
As of June 30, 2012, we had approximately $1.5 million in unrecognized compensation cost, net of estimated forfeitures, related to unvested share-based compensation awards.  This cost is expected to be recognized over a weighted average period of approximately 2.5 years.
 
 
8

 

In November 2011, we issued 800,000 restricted stock units (“RSUs”) to a consulting firm as a performance incentive in connection with a services agreement. These RSUs vest only upon achievement of certain market conditions, as measured based on the closing price of our common stock during a period ending on the earlier of (i) December 31, 2012 or (ii) thirty days following termination of the related consulting agreement.  The shares underlying this RSU are unregistered.   On June 30, 2012, 320,000 of these RSUs vested.  The fair market value of the vested RSUs, measured based on the closing price of our common stock on the date of vesting, was approximately $760,000 and was recognized in share-based compensation expense for the three and six months ended June 30, 2012.

During the six months ended June 30, 2012, we granted options to purchase an aggregate of 310,500 shares of our common stock to non-executive employees as long-term incentive compensation.  These options have exercise prices ranging from $0.80 to $2.26 per share, vest over a three to five-year period and expire seven years from the date of grant.  The aggregate grant date fair value of these awards, totaling approximately $297,000, will be recorded to share-based compensation expense over the requisite service period.

On April 5, 2012, we granted a stock option to purchase an aggregate of 50,000 shares of our common stock at an exercise price of $1.03 per share to an outside consultant as compensation under a consulting agreement.  This option is for unregistered shares and as of June 30, 2012, no shares have vested.  This option vests in four equal increments on July 1, 2012, October 1, 2012, January 1, 2013, and April 1, 2013 and expires six years from the grant date.  Upon thirty days’ notice, the consulting agreement may be terminated and any unvested portion of the option will be cancelled.   The fair value of this option was estimated during the option term using the Black-Scholes option pricing model with an expected term equal to the remaining contractual life, expected volatility of 93.4% and risk-free interest rates of 0.9%.  For the three and six months ended June 30, 2012, we recognized approximately $25,000 in share-based compensation expense related to this award.

9.   Stock Authorization and Issuance

We have filed two shelf registration statements with the SEC for purposes of providing flexibility to raise funds from the offering of various securities over a period of three years, subject to market conditions.   Securities offered under the shelf registration statements may be used to fund working capital, capital expenditures, vendor purchases, and other capital needs.  The first shelf registration statement (the “January 2009 Shelf”) for the offering of up to $25 million in securities was filed on January 5, 2009 (File No. 333-156571), declared effective on January 20, 2009, and expired in January 2012.  We issued an aggregate of $19.6 million in securities under the January 2009 Shelf.
 
The second shelf registration statement was filed on September 14, 2009 (File No. 333-161903) and was declared effective on September 30, 2009 for the offering of up to $50 million in securities (the “September 2009 Shelf”).  To date, we have issued an aggregate of approximately $36.7 million in securities under the September 2009 Shelf, including the offering discussed below.
 
On April 18, 2012, we completed the sale of an aggregate of 8,139,050 shares of our common stock, at a price of $1.05 per share, to a limited number of institutional and other investors in a registered offering under the September 2009 Shelf.  The offering represented 10.7% of our outstanding common stock on an after-issued basis.  The aggregate net proceeds from this offering were approximately $8.3 million, after deduction of placement agent fees and other offering costs.

During the three and six months ended June 30, 2012, we issued 1,608,831 shares of our common stock upon the exercise of warrants issued in connection with the sale of equity securities in 2010 and 2011.  We received proceeds from the exercise of these warrants of approximately $0.9 million which is included in the accompanying statement of cash flows.

 
9

 
 
10.   Fair Value Measurements

We have determined the estimated fair value amounts of our financial instruments using available market information.  Our assets that are measured at fair value on a recurring basis include the following as of June 30, 2012 and December 31, 2011:
 
 
Fair Value Measurements
   
 
 
 
Total
   
Quoted
Prices in
Active
Markets 
(Level 1)
   
Significant
Other
 Observable
Inputs
(Level 2)
   
Significant Unobservable
Inputs
(Level 3)
 
June 30, 2012:
                       
Available for sale securities:
                       
    Municipal bond mutual funds
  $ 6,642,573     $ 6,642,573     $ 0     $ 0  
                                 
 
 
Fair Value Measurements
 
   
 
 
 
Total
   
Quoted
Prices in
Active
Markets 
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant Unobservable
Inputs
(Level 3)
 
December 31, 2011:
                       
Available for sale securities:
                       
    Municipal bond mutual funds
  $ 5,026,398     $ 5,026,398     $ 0     $ 0  
                                 

11.  Commitments and Contingencies

Legal Proceedings
From time to time, we are subject to legal proceedings and claims which arise in the ordinary course of our business.  We believe, based upon advice from outside legal counsel, that the final disposition of such matters will not have a material adverse effect on our financial position, results of operations or liquidity.    

ParkerVision vs. Qualcomm, Inc.

In July 2011, we filed a complaint in the United States District Court of the Middle District of Florida against Qualcomm Incorporated (“Qualcomm”) seeking unspecified damages and injunctive relief for infringement of seven of our patents related to radio-frequency receivers and the down-conversion of electromagnetic signals (the “Complaint”).  Qualcomm filed an Answer and Counterclaim to our Complaint (the “Counterclaim”) in which Qualcomm denied infringement and alleged invalidity and unenforceability of each of our patents.  Qualcomm also named our long-time patent prosecution counsel, Sterne, Kessler, Goldstein & Fox PLLC (“SKGF”) as a co-defendant in its Counterclaim and further alleged that we aided and abetted SKGF in its alleged breach of fiduciary duty to Qualcomm and tortiously interfered with Qualcomm’s contractual relationship with SKGF.  In November 2011, we filed a motion to dismiss nine counts of Qualcomm’s Counterclaim and a motion to strike certain of Qualcomm’s affirmative defenses.  SKGF also filed a motion to dismiss Qualcomm’s claims against them.

In November 2011, Qualcomm also filed a motion for preliminary injunction against SKGF.  In February 2012, the court denied as moot Qualcomm’s motion for preliminary injunction.  Instead, the Court approved a protective order, which all parties negotiated and agreed to, that enables SKGF to continue
 
 
10

 
 
delivering legal advice and services to ParkerVision provided that they do not represent ParkerVision in the lawsuit or advise the Company regarding Qualcomm’s alleged infringement.

In February 2012, we filed an amended Complaint which dropped two patents from our original Complaint and added one patent which was not included in our original Complaint.  In March 2012, Qualcomm filed an amended Counterclaim which dropped two counts from the original Counterclaim.  Qualcomm also filed a motion to dismiss our claims of indirect patent infringement.  In April 2012, both ParkerVision and SKGF filed amended motions to dismiss Qualcomm’s Counterclaims.    The court has not yet ruled on these motions.

The court held a non-adversarial technology tutorial on July 24, 2012.  On August 6, 2012, the court held a claim construction hearing where we and Qualcomm presented our respective arguments for the proposed construction of disputed claim terms. The court has not yet issued a ruling on claim construction.  The court has set a deadline for fact discovery of November 30, 2012 and a trial date of August 5, 2013.   Discovery in the case is ongoing.  At this time, we do not believe it is possible to predict the outcome of these proceedings.

Maxtak Capital Advisors LLC vs. ParkerVision
On December 28, 2011, MaxTak Capital Advisors LLC, Maxtak Partners LP and David Greenbaum (the “Plantiffs”) filed a complaint in the United States District Court of New Jersey against us, our chief executive officer, Jeffrey Parker and one of our directors, Robert Sterne, alleging common law fraud and negligent misrepresentation of material facts concerning the effectiveness of our technology and our success in securing customers.  The Plantiffs are seeking unspecified damages, including attorneys’ fees and costs.  On March 3, 2012, we filed a motion to dismiss and a motion to transfer this case to the Middle District of Florida.  Rather than oppose the motions, on March 23, 2012, the Plantiffs filed an amended complaint.   In April 2012, we filed a motion to dismiss the amended complaint.  In May 2012, the Plantiffs filed a motion to strike certain evidence relied upon in our motion to dismiss.  In July 2012, the court determined that it would consider and rule on the motion to transfer before considering the motion to dismiss.   As such the court has administratively terminated the motion to dismiss pending a ruling on the motion to transfer.

We believe this matter is without merit and we do not anticipate that it will have a material adverse effect on our financial position, results of operations or liquidity.

ITEM 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public.  This report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, the statements about our future plans, objectives, and expectations contained in this Item.  When used in this report and in future filings by us the Securities and Exchange Commission (“SEC”), the words or phrases “will likely result”, “management expects”, “we expect”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.”  Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made.  Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2011 and in Item 2 of this report.  Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key business and sales relationships, reliance on our intellectual property, the outcome of litigation and the ability to obtain adequate financing in the future.  We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.
 
 
11

 

Overview

We are in the business of innovating fundamental wireless technologies.   We design, develop and market our proprietary RF technologies and products for use in semiconductor circuits for wireless communication products.  Since 2005, we have generated no product or royalty revenue from our wireless technologies.  We are heavily reliant on our relationship with VIA Telecom, Inc. (“VIA”) since our RF transmit product interfaces directly to VIA’s CDMA baseband processors.  We are currently working with VIA and one of their largest original equipment manufacturer (“OEM”) mobile handset customers on the design and test of a handset solution incorporating our technology, the successful completion of which, we believe, will lead to the incorporation of our technology into one or more of this OEM’s products.  The design and test process is being conducted primarily in Asia at VIA and/or the handset OEM’s facilities and, as a result, we have committed significant resources in personnel, travel and related costs for our engineering and sales team to this design and test process.

We are also currently engaged in patent litigation with Qualcomm Incorporated (“Qualcomm”) for their alleged infringement of a number of our patents that relate to a portion of our receiver intellectual property.  We believe the outcome of this litigation is critical to our ability to generate meaningful revenue from certain of our receiver technologies, and we intend to devote substantial resources to this litigation.  The court held a non-adversarial technology tutorial on July 24, 2012.  On August 6, 2012, the court held a claim construction hearing where we and Qualcomm presented our respective arguments for the proposed construction of disputed claim terms. The court has not yet issued a ruling on claim construction.  The court has set a deadline for fact discovery of November 30, 2012 and a trial date of August 5, 2013.   Discovery in the case is ongoing.  At this time, we do not believe it is possible to predict the outcome of these proceedings.  Although our litigation team is working on a partial contingency basis, we expect to incur significant costs for legal and expert fees related to this litigation.

The following discussion should be read along with the unaudited condensed financial statements included in this report, as well as our Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission on March 30, 2012, which provides a more thorough discussion of our products and services, industry outlook, and business trends.

Liquidity and Capital Resources

On April 18, 2012, we completed the sale of an aggregate of 8,139,050 shares of our common stock, at a price of $1.05 per share, to a limited number of institutional and other investors in a registered offering under our “shelf” registration statement originally filed in September 2009.  The offering represented 10.7% of our outstanding common stock on an after-issued basis.  The aggregate net proceeds from this offering were approximately $8.3 million, after deduction of placement agent fees and other offering costs.

As of June 30, 2012, we had working capital of approximately $6.1 million which represented an increase of approximately $1.6 million from working capital at December 31, 2011.  This increase in working capital is a result of approximately $8.3 million in net proceeds from the April 2012 offering and $0.9 million in proceeds from the exercise of stock options and warrants, less $6.9 million to fund operations and $0.6 million used for patents and fixed assets during the first half of 2012.   Our use of cash to fund operations increased approximately $2.1 million, or 42%, from the six months ended June 30, 2011 to the same period in 2012.  This increase in use of cash is primarily the result of an increase in litigation related expenses and other professional fees.

Our future business plans call for continued investment in sales, marketing, customer support and product development for our technologies and products, as well as investment in continued protection of our intellectual property including prosecution of new patents and defense of existing patents.  Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies, our ability to secure a reasonable share of the market through additional product offerings with our current customers and/or the addition of new customers, and our ability to defend our intellectual property, including our current litigation with Qualcomm.
 
 
12

 

Our revenue for 2012, if any, will not be sufficient to cover our operational expenses for 2012, and we expect that our expected continued losses and use of cash will be funded from our cash, cash equivalents and available for sale securities of $6.9 million at June 30, 2012.  In addition, we expect that available working capital may be used for initial production start-up costs, including test programs and production tooling, and for litigation expenses to defend our intellectual property.   We currently have no significant commitments for capital expenditures.

We believe our current capital resources may be sufficient to support our liquidity requirements through 2012; however, these resources will not be sufficient to support our liquidity requirements for the next twelve months without further cost containment measures that, if implemented, may jeopardize our future growth plans, including our ability to support initial production of our products.  We believe we may be able to meet future liquidity needs through the issuance of equity securities under our outstanding shelf registration statement or in private placements or through short or long-term debt financing, although there can be no assurance that such financing will be available to us.  We currently have no significant long-term debt obligations.

The long-term continuation of our business plan through 2012 and beyond is dependent upon the generation of sufficient revenues from our technologies and products to offset expenses.  In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or further reduce operating costs.  Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or further reduce operating costs could have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

Results of Operations for Each of the Three and Six months Ended June 30, 2012 and 2011

Revenue and Gross Margin
We had no product or royalty revenue for the three or six months ended June 30, 2012 or 2011.  We are currently working with VIA and one of their largest OEM mobile handset customers on the design and test of a handset solution incorporating our technology, the successful completion of which, we believe, will lead to the incorporation of our technology into one or more of this OEM’s products.  To the extent that our technology is incorporated in the form of integrated circuits supplied by us, additional working capital may be needed to support production start-up costs including test programs and production tooling.

Research and Development Expenses
Research and development expenses consist primarily of engineering and related management and support personnel costs; fees for outside engineering design services which we use from time to time to supplement our internal resources; amortization and depreciation expense related to our patents and other assets used in product development; prototype production and materials costs, which represent the fabrication and packaging costs for prototype integrated circuits, as well as the cost of supporting components for prototype board development; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and rent and other overhead costs for our engineering design facility.  Personnel costs include share-based compensation amounts which have been determined based on the grant date fair value of equity-based awards to our employees and then recorded to expense over the vesting period of the award.

Our research and development expenses decreased approximately $397,000, or 18%, during the three months ended June 30, 2012 when compared to the same period in 2011.   This decrease is primarily due to reduced employee share-based compensation of approximately $268,000 and decreases in outside professional fees of approximately $165,000.

Our research and development expenses decreased approximately $296,000, or 7%, during the six months ended June 30, 2012 when compared to the same period in 2011.   This decrease is primarily due to reduced employee share-based compensation expense of approximately $389,000 and decreases in
 
 
13

 
 
outside professional fees of approximately $291,000.  These decreases were partially offset by an increase in personnel and related expenses, excluding share-based compensation, of approximately $208,000 an increase in software licensing and support costs of approximately $72,000, and an increase in prototype production and material costs of approximately $65,000.

The decrease in share-based compensation for the three and six month periods ended June 30, 2012 is primarily the result of certain executive and employee RSU awards from prior years becoming fully vested in mid-2011.  Although new executive and employee awards were granted in 2011, the grant-date fair value of these new awards is significantly lower than the prior years’ awards due to the type of award and the market price of our common stock on the award date.  The decrease in outside professional fees for the three and six month periods ended June 30, 2012 is the result of a decrease in outside design services due to timing of certain projects as well as a decrease in legal fees related to patent prosecution.

The increase in personnel and related costs for the six month period ended June 30, 2012 is primarily the result of the addition of new employees in mid-2011.  The increase in software licensing and support costs for the six month period ended June 30, 2012 is a result of changes in the software tools necessary to support our product designs and the increase in prototype production and material costs is due to timing of certain design projects.

We expect a significant percentage of our current working capital will be invested in our research and product development activities throughout 2012. However, these expenses will fluctuate on a quarter to quarter basis depending on the timing of various projects.

Marketing and Selling Expenses
Marketing and selling expenses consist primarily of marketing and sales personnel costs, including share-based compensation and travel costs, and outside professional fees.  Marketing and selling expenses increased approximately $25,000, or 7%, during the three months ended June 30, 2012 when compared to the same period in 2011.  This increase is primarily due to an increase in outside professional fees of approximately $57,000 partially offset by a decrease in employee share-based compensation expense of approximately $22,000.

Marketing and selling expenses increased approximately $79,000, or 12%, during the six months ended June 30, 2012 when compared to the same period in 2011.  This increase is primarily due to an increase in outside professional fees of approximately $136,000 partially offset by a decrease in employee share-based compensation of approximately $56,000.

This increase in outside professional fees for the three and six month periods ended is a result of outsourced support for a VIA customer in Asia and the initiation of certain public relations activities late in 2011.  The decrease in share-based compensation for the three and six month periods ended June 30, 2012 is primarily the result of certain executive and employee RSU awards from prior years becoming fully vested in mid-2011.  Although new executive and employee awards were granted in 2011, the grant-date fair value of these new awards is significantly lower than the prior years’ awards due to the type of award and the market price of our common stock on the award date.

General and Administrative Expenses
General and administrative expenses consist primarily of executive, director, finance and administrative personnel costs, including share-based compensation, and costs incurred for insurance, shareholder relations and outside professional services, including litigation and other legal services.

General and administrative expenses increased approximately $1,883,000, or 180%, during the three months ended June 30, 2012 when compared to the same period in 2011.  This increase is primarily due to an increase in share-based compensation expense of approximately $853,000, an increase in outside legal fees of approximately $727,000, and an increase in outside consulting fees of approximately $121,000.
 
 
14

 
 
General and administrative expenses increased approximately $2,415,000, or 112%, during the six months ended June 30, 2012 when compared to the same period in 2011.  This increase is primarily due to increases in outside legal fees of approximately $1,182,000, share-based compensation expense of approximately $875,000, and outside consulting fees of approximately $175,000.

This increase in legal fees is primarily a result of expenses related to the Qualcomm litigation.  The increase in outside consulting fees is primarily the result of engagements with consulting firms to assist with various shareholder relations activities and compensation plans.  The increase in share-based compensation for the three and six month periods ended June 30, 2012 is primarily the result of performance based vesting of restricted stock units issued to a third-party in November 2011.

Net Loss and Net Loss per Common Share
Our net loss increased approximately $1,523,000, or 43%, during the three months ended June 30, 2012 when compared to the same period in 2011.  This increase is a result of the $1,511,000, or 42%, increase in operating expenses.  On a per share basis, our loss increased $0.01 per common share, or 17%, for the three months ended June 30, 2012 when compared to the same period in 2011.  This increase is a result of the increase in operating expenses offset by a 26% increase in the weighted average shares outstanding for the period.

For the six months ended June 30, 2012, our net loss increased approximately $2,221,000, or 32%, when compared to the same period in 2011.  This increase is a result of the $2,198,000, or 32%, increase in operating expenses. On a per share basis, our loss increased $0.01 per common share, or 8%, for the six months ended June 30, 2012 when compared to the same period in 2011.  This increase is a result of the increase in operating expenses offset by a 27% increase in the weighted average shares outstanding for the period.

Off-Balance Sheet Transactions, Arrangements and Other Relationships
As of June 30, 2012, we had outstanding warrants to purchase 3,213,738 shares of common stock that were issued in connection with the sale of equity securities in various public and private placement transactions in 2009, 2010, and 2011. These warrants have exercise prices ranging from $0.54 to $1.88 per share, with a weighted average exercise price of $0.78 and a weighted average remaining contractual life of approximately 3.3 years.  The estimated fair value of these warrants of $1,323,305 is included in shareholders’ equity in our balance sheets.

Critical Accounting Policies
There have been no changes in critical accounting policies from those stated in our Annual Report on Form 10-K for the year ended December 31, 2011.

ITEM 3.  Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

ITEM 4.  Controls and Procedures.

Evaluation of Disclosure Controls and Procedures
As of June 30, 2012, an evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934).   Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of June 30, 2012.  

 
15

 

Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
PART II - OTHER INFORMATION

ITEM 1.  Legal Proceedings.

Refer to “Legal Proceedings” in Note 11 to our financial statements for a discussion of current legal proceedings.

ITEM 1A.  Risk Factors.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2011.  In addition to the information in this report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

On April 5, 2012, we issued an option to purchase 50,000 shares of our common stock, at an exercise price of $1.03 per share, to one of our vendors in exchange for services valued at approximately $39,000.  The option vests in equal increments on July 1, 2012, October 1, 2012, January 1, 2013, and April 1, 2013.  The option expires on April 6, 2018.  The option was issued pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, as the option was sold to a sophisticated investor, with such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the investment, in a transaction not involving a public offering.

ITEM 3.  Defaults Upon Senior Securities.

None.

ITEM 4.  Mine Safety Disclosures.

Not applicable.

ITEM 5.  Other Information.

In accordance with and satisfaction of the requirements of Item 2.02 of Form 8-K, we include the following disclosure:

On August 14, 2012, we issued a press release announcing our results of operations and financial condition for the three and six months ended June 30, 2012.  The press release is attached hereto as Exhibit 99.1.

ITEM 6.  Exhibits

3.1
Articles of Incorporation, as amended (incorporated by reference from Exhibit 3.1 of Registration Statement No. 33-70588-A)
3.2
Amendment to Amended Articles of Incorporation dated March 6, 2000 (incorporated by reference from Exhibit 3.2 of Annual Report on Form 10-K for the year ended December 31, 1999)
 
 
16

 
 
3.3
Bylaws, as amended (incorporated by reference from Exhibit 3.1 of Current Report on Form 8-K filed August 10, 2008)
10.1
Form of Securities Purchase Agreement between ParkerVision, Inc. and the purchasers identified on the signature pages thereto (incorporated by reference from Exhibit 10.1 of Current Report on Form 8-K filed April 13, 2012)
31.1
Section 302 Certification of Jeffrey L. Parker, CEO*
31.2
Section 302 Certification of Cynthia Poehlman, CFO*
32.1
Section 906 Certification*
99.1
Earnings Press Release*
101.INS
XBRL Instance Document*
101.SCH
XBRL Taxonomy Extension Schema*
101.CAL
XBRL Taxonomy Extension Calculation Linkbase*
101.DEF
XBRL Taxonomy Extension Definition Linkbase*
101.LAB
XBRL Taxonomy Extension Label Linkbase*
101.PRE
XBRL Taxonomy Extension Presentation Linkbase*

*Included herewith

 
17

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
ParkerVision, Inc.
 
Registrant
 
August 14, 2012
By:
/s/ Jeffrey L. Parker
 
 
Jeffrey L. Parker
 
 
Chairman and Chief Executive Officer
 
 
(Principal Executive Officer)
 
       
       
August 14, 2012
By:
/s/ Cynthia L. Poehlman
 
 
Cynthia L. Poehlman
 
 
Chief Financial Officer
 
 
(Principal Financial Officer and Principal
 
 
Accounting Officer)
 

 
18

 

EXHIBIT INDEX
 
31.1
Section 302 Certification of Jeffrey L. Parker, CEO
31.2
Section 302 Certification of Cynthia Poehlman, CFO
32.1
Section 906 Certification
99.1
Earnings Press Release
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema
101.CAL
XBRL Taxonomy Extension Calculation Linkbase
101.DEF
XBRL Taxonomy Extension Definition Linkbase
101.LAB
XBRL Taxonomy Extension Label Linkbase
101.PRE
XBRL Taxonomy Extension Presentation Linkbase
 
 
19